110 related articles for article (PubMed ID: 21902730)
1. Stimulating beta cell replication and improving islet graft function by GPR119 agonists.
Gao J; Tian L; Weng G; Bhagroo NV; Sorenson RL; O'Brien TD; Luo J; Guo Z
Transpl Int; 2011 Nov; 24(11):1124-34. PubMed ID: 21902730
[TBL] [Abstract][Full Text] [Related]
2. Stimulating β-cell replication and improving islet graft function by AR231453, A GPR119 agonist.
Gao J; Tian L; Weng G; O'Brien TD; Luo J; Guo Z
Transplant Proc; 2011 Nov; 43(9):3217-20. PubMed ID: 22099761
[TBL] [Abstract][Full Text] [Related]
3. Activation of GPR119 Stimulates Human β-Cell Replication and Neogenesis in Humanized Mice with Functional Human Islets.
Ansarullah ; Free C; Christopherson J; Chen Q; Gao J; Liu C; Naji A; Rabinovitch A; Guo Z
J Diabetes Res; 2016; 2016():1620821. PubMed ID: 27413754
[TBL] [Abstract][Full Text] [Related]
4. Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells.
Ning Y; O'Neill K; Lan H; Pang L; Shan LX; Hawes BE; Hedrick JA
Br J Pharmacol; 2008 Dec; 155(7):1056-65. PubMed ID: 18724386
[TBL] [Abstract][Full Text] [Related]
5. Stimulating β-cell regeneration by combining a GPR119 agonist with a DPP-IV inhibitor.
Ansarullah ; Lu Y; Holstein M; DeRuyter B; Rabinovitch A; Guo Z
PLoS One; 2013; 8(1):e53345. PubMed ID: 23382843
[TBL] [Abstract][Full Text] [Related]
6. Activation of GPR119 by fatty acid agonists augments insulin release from clonal β-cells and isolated pancreatic islets and improves glucose tolerance in mice.
Moran BM; Abdel-Wahab YH; Flatt PR; McKillop AM
Biol Chem; 2014 Apr; 395(4):453-64. PubMed ID: 24323890
[TBL] [Abstract][Full Text] [Related]
7. Comparison of exendin-4 on beta-cell replication in mouse and human islet grafts.
Tian L; Gao J; Weng G; Yi H; Tian B; O'Brien TD; Guo Z
Transpl Int; 2011 Aug; 24(8):856-64. PubMed ID: 21627696
[TBL] [Abstract][Full Text] [Related]
8. Bidirectional GPR119 Agonism Requires Peptide YY and Glucose for Activity in Mouse and Human Colon Mucosa.
Tough IR; Forbes S; Herzog H; Jones RM; Schwartz TW; Cox HM
Endocrinology; 2018 Apr; 159(4):1704-1717. PubMed ID: 29471473
[TBL] [Abstract][Full Text] [Related]
9. Novel GPR119 agonist HD0471042 attenuated type 2 diabetes mellitus.
Ha TY; Kim YS; Kim CH; Choi HS; Yang J; Park SH; Kim DH; Rhee JK
Arch Pharm Res; 2014 May; 37(5):671-8. PubMed ID: 23897163
[TBL] [Abstract][Full Text] [Related]
10. GPR119 is required for physiological regulation of glucagon-like peptide-1 secretion but not for metabolic homeostasis.
Lan H; Vassileva G; Corona A; Liu L; Baker H; Golovko A; Abbondanzo SJ; Hu W; Yang S; Ning Y; Del Vecchio RA; Poulet F; Laverty M; Gustafson EL; Hedrick JA; Kowalski TJ
J Endocrinol; 2009 May; 201(2):219-30. PubMed ID: 19282326
[TBL] [Abstract][Full Text] [Related]
11. The cytoprotective effects of oleoylethanolamide in insulin-secreting cells do not require activation of GPR119.
Stone VM; Dhayal S; Smith DM; Lenaghan C; Brocklehurst KJ; Morgan NG
Br J Pharmacol; 2012 Apr; 165(8):2758-70. PubMed ID: 22029844
[TBL] [Abstract][Full Text] [Related]
12. GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell.
Lauffer LM; Iakoubov R; Brubaker PL
Diabetes; 2009 May; 58(5):1058-66. PubMed ID: 19208912
[TBL] [Abstract][Full Text] [Related]
13. Agonists at GPR119 mediate secretion of GLP-1 from mouse enteroendocrine cells through glucose-independent pathways.
Lan H; Lin HV; Wang CF; Wright MJ; Xu S; Kang L; Juhl K; Hedrick JA; Kowalski TJ
Br J Pharmacol; 2012 Apr; 165(8):2799-807. PubMed ID: 22029751
[TBL] [Abstract][Full Text] [Related]
14. Biased signaling of lipids and allosteric actions of synthetic molecules for GPR119.
Hassing HA; Fares S; Larsen O; Pad H; Hauge M; Jones RM; Schwartz TW; Hansen HS; Rosenkilde MM
Biochem Pharmacol; 2016 Nov; 119():66-75. PubMed ID: 27569424
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for constitutive activity and agonist-induced activation of the enteroendocrine fat sensor GPR119.
Engelstoft MS; Norn C; Hauge M; Holliday ND; Elster L; Lehmann J; Jones RM; Frimurer TM; Schwartz TW
Br J Pharmacol; 2014 Dec; 171(24):5774-89. PubMed ID: 25117266
[TBL] [Abstract][Full Text] [Related]
16. A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release.
Chu ZL; Jones RM; He H; Carroll C; Gutierrez V; Lucman A; Moloney M; Gao H; Mondala H; Bagnol D; Unett D; Liang Y; Demarest K; Semple G; Behan DP; Leonard J
Endocrinology; 2007 Jun; 148(6):2601-9. PubMed ID: 17289847
[TBL] [Abstract][Full Text] [Related]
17. GPR119 regulates genetic markers of fatty acid oxidation in cultured skeletal muscle myotubes.
Cornall LM; Mathai ML; Hryciw DH; Simcocks AC; O'Brien PE; Wentworth JM; McAinch AJ
Mol Cell Endocrinol; 2013 Jan; 365(1):108-18. PubMed ID: 23069642
[TBL] [Abstract][Full Text] [Related]
18. Regulation of GPR119 receptor activity with endocannabinoid-like lipids.
Syed SK; Bui HH; Beavers LS; Farb TB; Ficorilli J; Chesterfield AK; Kuo MS; Bokvist K; Barrett DG; Efanov AM
Am J Physiol Endocrinol Metab; 2012 Dec; 303(12):E1469-78. PubMed ID: 23074242
[TBL] [Abstract][Full Text] [Related]
19. A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release.
Chu ZL; Carroll C; Alfonso J; Gutierrez V; He H; Lucman A; Pedraza M; Mondala H; Gao H; Bagnol D; Chen R; Jones RM; Behan DP; Leonard J
Endocrinology; 2008 May; 149(5):2038-47. PubMed ID: 18202141
[TBL] [Abstract][Full Text] [Related]
20. GPR119 Agonism Increases Glucagon Secretion During Insulin-Induced Hypoglycemia.
Li NX; Brown S; Kowalski T; Wu M; Yang L; Dai G; Petrov A; Ding Y; Dlugos T; Wood HB; Wang L; Erion M; Sherwin R; Kelley DE
Diabetes; 2018 Jul; 67(7):1401-1413. PubMed ID: 29669745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]